Zhejiang Shengda Bio-Pharm Dividends and Buybacks
Dividend criteria checks 0/6
Zhejiang Shengda Bio-Pharm is a dividend paying company with a current yield of 0.39%.
Key information
0.4%
Dividend yield
0.3%
Buyback Yield
Total Shareholder Yield | 0.7% |
Future Dividend Yield | n/a |
Dividend Growth | -5.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.060 |
Payout ratio | -33% |
Recent dividend and buyback updates
Recent updates
Subdued Growth No Barrier To Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) With Shares Advancing 28%
Oct 28What Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) 27% Share Price Gain Is Not Telling You
Aug 08Revenues Working Against Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) Share Price Following 26% Dive
Jun 12Zhejiang Shengda Bio-Pharm Co., Ltd.'s (SHSE:603079) 30% Dip In Price Shows Sentiment Is Matching Revenues
Apr 25Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) Surges 31% Yet Its Low P/S Is No Reason For Excitement
Mar 08Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 603079 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 603079 has only been paying a dividend for 6 years, and since then payments have fallen.
Dividend Yield vs Market
Zhejiang Shengda Bio-Pharm Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (603079) | 0.4% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.2% |
Industry Average (Pharmaceuticals) | 1.7% |
Analyst forecast (603079) (up to 3 years) | n/a |
Notable Dividend: 603079's dividend (0.39%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 603079's dividend (0.39%) is low compared to the top 25% of dividend payers in the CN market (2.16%).
Earnings Payout to Shareholders
Earnings Coverage: 603079 is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: 603079 is paying a dividend but the company has no free cash flows.